Chen et al. performed a comparison of FAP-specific to FDG PET that contained 4 glioma patients (2 GBM, 1 grade II glioma, 1 grade III glioma) and noted that while the absolute uptake was lower for FAP-specific PET, the tumor-to-background ratio was higher [12]. The gene discussed is FAP; the disease is glioma.